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1. Introduction
Mental retardation(MR) was defined by the World Health Organisation as an intelligent
quotient (IQ)<70 that is accompanied by adaptive limitations in two or more key skills areas,
before the age of 18. General intellectual functioning is expressed by IQ. Typically, in chil‐
dren younger than 5 years old who present delays in the attainment of developmental mile‐
stones at the expected age, the term of "developmental delay" is used. Also, developmental
delay is used before the age of 5,when IQ testing is reliable and valid and it takes into con‐
sideration learning and adaptive deficits which predict later intellectual disability.
Different classifications have been used to partition people with MR, the most frequent, ac‐
cepted also by DSM IV (American Psychiatry Association) based on performances on stand‐
ardised cognitive tests: mild (IQ 50-70), moderate (IQ 35-49), severe ( IQ 20-34) and
profound (IQ <20). [1]
According to this type of classification the level of difficulties and everyday life needs for
the social and psychological support of a person affected by MR, can be established.
The definition and classification tend to accept the diagnosis of non-progressive form identi‐
fiable in small babies. In clinical practice, metabolic or neurodegenerative disorders may as‐
sociate MR, frequently a progressive form, in children prior having normal development.
Adrenoleukodystrophy manifests with progressive cognitive regression in boys, after a peri‐
od of normal development. In addition, a pervasive developmental disorder manifested
through cessation and regression of normal development, associating seizures and mycroce‐
phaly in small girls is rather included in mental regression, only after a clear clinical picture
in syndromal MR. The clinical association between MR and malformations, neurological dis‐
functions such as epilepsy or cerebral palsy, sensorial deficits, other maladies or behaviour
disturbances are usually earlier directed to evaluation and medical care.
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Having such an impact on life, MR is one of the most frequent causes for genetic evaluation
in babies in developped countries. Developmental screening addresses those who have de‐
velopmental delays identifiable in primary care and need referral for furher evaluation.
2. The causes of mental retardation
MR has heterogeneous environmental and genetic causes acting invarious phases of pre,
peri and postnatal development.
Pre
na
tal
Environmental factors
   -Deficiencies , such as iodine deficiency and folic acid
  deficiency
  -Severe malnutrition in pregnancy-Rh incompatibility
  -Using substances such as alcohol (maternal alcohol
  syndrome), nicotine, and cocaine during early pregnancy
  -Exposure to other harmful chemicals such as pollutants,
  heavy   metals, and harmful medications such as thalidomide,
  phenytoin and warfarin sodium in early pregnancy
  -Maternal infections such as rubella, syphilis, toxoplasmosis,
  cytomegalovirus and HIV       
  -Others such as excessive exposure to radiation
Chromosomal
abnormalities(cytogenetic techniques)
 
  Trisomy 21
  Partial trisomies (e.g., 4p, 9q) 
  Aneusomies of the X chromosome 
  Partial deletions (eg, 5p-/cri de chat) 
  Translocations
Cryptic chromosomal
abnormalities(complex methods)
  -Microdeletions or microduplications of chromosomal          
    segments
    Wolf-Hirschhorn syndrome
    Pallister-Killian syndrome
    18p deletion
 -Cryptic subtelomeric rearrangements (eg, deletions,
     duplications) 
    -Cryptic interstitial rearrangements - microdeletion :
 ά-thalassemia with mental retardation ,Smith Magenis
 syndrome (deletie 17p11.2.) , Rubinstein-Taybi syndrome
   (16p13.3)
   -Cryptic interstitial rearrangements - duplications:
    15q11-13 duplication: Kabuki Makeup syndrome
    -Contigous gene syndrome
Mutation of a single gene X-linked mental retardationMowat-Wilson syndrome
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Cornelia de Lange syndrome
Lissencephaly with cerebellar hypoplasia
Walker–Warburg syndrome (also known as HARD syndrome)
Muscle–eye–brain disease (MEB)
Fukuyama congenital muscular dystrophy (FCMD) with type 2
lissencephaly
Neurofibromatosis type 1 (NF1);
Cerebral malformations
Pe
rin
ata
l
3rdtrimester Complications of pregnancy Diseases in mother such as heartand kidney disease and diabetes Placental dysfunction
During delivery
Severe prematurity, very low birth weight, birth asphyxia
Difficult and/or complicated delivery Birth trauma, vascular
accidents
Neonatal Septicemia, severe jaundice, hypoglycemia   
Po
stn
ata
l  (
in 
inf
an
cy
 an
d c
hil
dh
oo
d)
 Traumatic, accidental, infectious
Brain infections such as tuberculosis, encephalitis, and bacterial
meningitis Head injury Chronic lead exposure Severe and
prolonged malnutrition Gross under stimulation
MR that develops after a period of
normal development
Lysosomal storage diseases
Peroxizomal disorders
Exposure to heavy metals, pesticide, malnutrition
Multifactorial or complex inheritance
MR
Table 1. Causes of mental retardation in regards to development stage.
Current research has been directed to clarify the genetic base of what was accepted as 'idio‐
pathic MR'. The initial reports about the implication of telomeric rearrangements in MR eti‐
ology created the necessity of a screening method. The prevalence of this type of
modification was established at 5%, being higher in severe mental retardation group, nearly
half of all being de novo mutations. The tendency to find a phenotype associated remained
unfulfilled partly because of the reduced number of cases and partly because of the hetero‐
geneity of the rearrangements. Deletion of the majority of end chromosomes were implicat‐
ed in MR, some causing clinical recognizable syndromes such as Wolf-Hirchorn or Miller-
Dieker syndromes.
By contrast, interstitial rearrangements are always clinically expressed by MR and cause rec‐
ognizable phenotypic features. Submicroscopic deletions are responsible for the learning
disabilities, velo-cardio-facial malformations from DiGorges syndrome (22q11 deletion), rec‐
ognisable asymmetric cognition profile in Williams–Beuren syndrome (7q11.2 deletion) or
cognitive and growth retardation from Smith–Magenis syndrome (17p11.2 deletion). The
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use of genomewide microarray-CGH has implicated interstitial chromosomal deletions or
duplications in a significant part of unexplained MR so far.
MR can be part of a complex cognitive impairment in disorders caused by deregulations in
imprinted genes. As examples, there are the Angelman syndrome and Prader Willi syn‐
drome, both associated with microdeletions of the same region corresponding to 15q11.2–
15q13, the paternally derived chromosome 15 causing PWS, and the maternally derived
chromosome 15 causing AS.
A mutation in a single gene, should intervene in the biological mechanism of MR. A dys‐
functional protein coded by this gene can deregulate functional cellular pathways or proc‐
esses, influencing cellular connectivity, synaptic structure or function. As the result of this
common genetic and physiopathological mechanism cerebral complex functions are im‐
paired, the clinical expression being a limited ability to process information. Abnormalities
of genes function may be implicated in almost any biological process that the cell conducts:
DNA replication repair and recombination, translation, control of gene expression, mem‐
brane structure, membrane transport, energy conservation, cell communication, the cytoske‐
leton, cell life and division cycle. In an attempt of classify MR genes, two categories were
taken into consideration: one including genes implicated in brain development, neurogene‐
sis and neuronal migration, for which MR may be considered to be a secondary symptom
due to brain malformation, and another one having those genes responsible for MR condi‐
tions without apparent brain abnormalities.
The list of indentified genes associated with MR is constantly growing. Using OMIM data‐
base entries and recent epidemiological studies the relative distribution of MR genes has
been analysed. From the approximately 282 human MR genes, 16% reside on chromosome
X, whereas its content represents only 3.37–4% of all known and predicted genes. The major‐
ity of known mutations in X-linked genes are loss-of-function mutations. Citation
X-linked forms of mental retardation are estimated to cause 10-20% of all inherited cases of
mental retardation. The first gene to be identified was FMR1 that causes fragile X syndrome
and still remains the commonest single gene abnormality to be identified. The prevalence of
many mutations isvery rare, many X-linked mental retardation disorders being present only
in a limited number of patients. The future of microarray technology will enhance the diag‐
nostic possibilities of cases suspected of X-linked mental retardation. Screening candidates
are CGG repeat expansion in the fragile X-syndrome, the A140V and the mutation in the
MECP2 gene.
2.1. Chromosomal abnormalities
Autosomal chromosom aneuploidies
Aberrations in autosomal chromosome number in live born babies are restricted to
aneuploidies: trisomy 13 (Patau's syndrome), 18 (Edward's syndrome) and trisomy 21
(Down syndrome), monosomy of any autosomal chromosome being lethal in the earliest
stages of embryonic life. Malformations’ severity can be lethal in the first week of life for
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newborns with Patau or Edward's syndrome; otherwise the level of functioning and cogni‐
tive development is severely affected.
Down syndrome(DS)
Down syndrome is the most frequent genetic cause of mental retardation. Results of stand‐
ardized intelligence test IQ scores, in Down syndrome, may vary from low normal to se‐
verely retarded 85-20, dependent on the degree of cognitive deficits. Children with
mosaicism may obtain scores with 10-30 point higher on IQ measurement that those with
trisomy 21. [4,5] Longitudinal observation findings regarding cognitive development sus‐
tained that learning in children with Down syndrome may continue through late childhood
and adolescence.
Early identified difficulties in achieving developmental milestones and learning disabilities,
especially with language, create the opportunity of adequate education thus promoting a
better social adaptation. Children with Down syndrome may present developmental stages
similar to other children in the domain of sensoriomotor, adaptive and social interaction
skills but with a slower rate.[2] Examination of developmental scores of young children with
DS aresimilar with those of normal children, in Personal, Social and Adaptive Domains. De‐
velopmental scores are less similar in Communication and Cognitive Domains of the Bat‐
telle Developmental Inventory this being more evident as they approached 36thmonth. [3]
Neuropathological studies in Down syndrome showed that persistent hypocellularity to be
one cause of intellectual disability. In DS individuals, cell density revealed reduced neuron
number in late gestation (after weeks 19–23) by comparison with early gestation [6,7,8]. The
same cellular reduction is maintained from the fetal age, through newborn period in the hip‐
pocampus, parahippocampalgyrus, cerebellum and neocortex. [6,7,9] Reduced volumes of
the hippocampus, entorhinal, frontal, prefrontal, and temporal cortices, amygdala, cerebel‐
lum, brain stem nuclei, and mammillary bodies of the hypothalamus have been found in
children and adults with DS. [10,11]
Autosomal structural anomalies
Wolf-Hirschhorn syndrome
Wolf-Hirschhorn syndrome(WHS) deletion of genetic material near the end of the short (p)
arm of chromosome 4(4p-) the critical region- 4p16.3. The size of the deletion varies among
affected individuals, larger deletions associate more severe intellectual disability and physi‐
cal abnormalities than smaller deletions. A combination of Chromosomal microarray
(CMA), FISH, and/or G-banded cytogenetic studies may be necessary for complete charac‐
terization of the chromosomerearrangement. [12]
The phenotype is dominated by prenatal and postnatal growth delay, a facial appearance of
"Greek warrior helmet " with microcephaly, high forehead, broad bridge of the nose con‐
tinuing to the forehead, hypertelorism, epicanthus, highly arched eyebrows, short philtrum,
downturned mouth, micrognathia, and poorly formed ears, congenital heart and urinary de‐
fect and skeletal anomalies. [13] Central nervous system defects, sensorial defects (hearing
and seeing), hypotonia and seizures complete the panel of intellectual disability. One third
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of the individuals with WHS have mild to moderate mental retardation. Battaglia et al [2008]
found mild mental retardation in 10% of the patients, moderate in 25%, and severe/
profound in 65%. [14]
Phenotypic expression of WHS is related to the loss of multiple genes on the short arm of
chromosome 4. From these, the lost of WHSC1, LETM1, and MSX1 is correlated with typical
signs and symptoms of this disorder.
Cri du Chat syndrome
Cri du Chat syndrome (CdCS) is caused by a deletion of variable size occurring on the short
arm of chromosome 5 (5p-). Localization of the deletion can be terminal, 5p terminal, in the
majority of cases, but also we can find interstitial deletion, de novo translocation and familial
translocation.
Imagistic findings in CdCS, especially MRI, were atrophy of the brainstem mainly involving
the pons, cerebellum, median cerebellar peduncles and cerebellar white matter. [15]
Recent studies attempted to correlate genetic substrate with cognitive develop and behav‐
ioural pattern. The first assumption that any break point on chromosome 5 produces a typi‐
cal phenotype of CdCS was modified by the newest studies results. In this way two distinct
regions were implicated: one for the cat-like cry in 5p15.3 (between loci D5S13 and D5S760)
and the other for dysmorphism, microcephaly, and mental retardation in 5p15.2 (between
loci D5S23 and D5S791).
In 5p15.2 region, two separate subregions were also mapped: one for childhood facial dys‐
morphism and moderate mental retardation and the other for adult facial dysmorphism and
severe mental retardation. The involvement in brain development and function, suggested
by the presence of mental retardation may be sustained by the mapping of different genes
(SEMAF,CTNND2) in this region.
CTNND2 gene codes a protein called delta-catenin involved in cell adhesion and move‐
ment. For example in a developing brain it is involved in neuronal migration, serving as a
guide for nerve cell proper positions. In mature nerve cells delta-catenin has a role in synap‐
ses functioning. The disruption of these processes may be the fundament of the severe intel‐
lectual disability in individual who have CdCS and loss of CTNND2. [16]
SEMAF gene code a protein called Semaphorine F, in axonal guidance during neural devel‐
opment. The importance for axonal guidance and neuronal precursors migration during
cortical development had been prooven in mice, suggesting that SEMAF may be responsible
for some of the features of CdCS. [17]
Deletion of 5p15.3 was identified in individuals with speech delay but with no major intel‐
lectual impairment, also with subjects milder degree of cognitive impairment and fewer be‐
havioural problems than those with deletion breakpoints in p15.2.[18] This region was
implicated by abnormal gene expression in anomalous cerebral lateralisation which support
the hypothesis of a separate region for the speech delay distal of p15.3 In general, individu‐
als have delayed speech and language development, some never develop spoken language.
Their receptive language is better than their expressive language, although both are delayed.
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Subjects with deletion breakpoints in 5p15.3 had a milder degree of cognitive impairment
and fewer behavioural problems than those with deletion breakpoints in p15.2. [19]
Pallister-Killian Syndrome
In people with Pallister-Killian mosaic syndrome (PKS) some cells have 2 extra copies of the
short, p, arm of chromosome 12 fusionated as isochromosome 12p or i(12p). The genetic ma‐
terial from the isochromosome disrupts the normal course of development, causing the
characteristic features of this disorder. The phenotypic expression is variable and also all af‐
fected children have mosaic tetrasomy 12p, onlythose who have a complete phenotype can
be said to have PKS.
PKS is considered a neurodevelopmental disorder.PKS children experience learning disabil‐
ities some of them only mild but the majority severe to profound. Speech tends to be late, is
often limited and sometimes absent. The learning processes may be influenced by the senso‐
rial deficits (hearing and vision) and by the reduced interest for communication and the lack
of eye contact reported by parents in the early years.
They have the ability to communicate their needs and preferences using gestures and vocal
noises, since preschool and later they can attend special schools with dedicated support worker.
18p deletion
18p deletion or “18p-” means that part or the entire short arm of chromosome 18 is missing,
or deleted, the individuals having only one of two copies of chromosome 18short arm. In
some patients, this deletion is the only chromosomal change, in others can be the result of a
more complex modification, for example an unbalanced translocation. People with an unbal‐
anced translocation may have features of 18p- as well as features of the chromosome dupli‐
cation. Atypical phenotype in a child with 18p- may is an argument to analyze the
subtelomeric regions of all the chromosomes. [20]
Clinical phenotype at birth presents low weight, microcephaly, rectangular face, ptosis, epi‐
canthal folds, low nasal bridge, hypertelorism, high-arched palate, prominent philtrum and
large protruding ears. They may have low muscle tone – hypotonia and other neurological
manifestation: a higher risk to associate holoprosencephaly, seizures and dystonia.
Holoprosencepahly may be severe in some newborn influencing survival, in others individ‐
uals milder forms causing brain minor changes, such as a missing corpus callosum, hydroce‐
phalus or a change in the structure of the pituitary gland. Cerebral changes may be
recognised in facial features such cleft lip and palate or hypotelorism or single incisor at the
midline of the mouth.
Children may show delay in achieving milestones, mostly in the motor and verbal field.
They may take longer to roll over, to sit, crawl and walk, and also language skills may de‐
velop later.
People with 18p- may manifest a variable degree of cognitive disabilities, tested IQ scores
range from average to severe mental retardation.
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Sex chromosomal aneuploidies
Turner syndrome(45X0)
Typically, genetic diagnosis of Turner syndrome had been done in adolescence, when pub‐
erty had fails to install. Although initially disregarded, many years after diagnosis the pa‐
tients were considered to have mental retardation. Numerous researches showed lower
Performance IQ than Verbal IQ and deficiency in nonverbal, visuo-spatial areas.
Psychosocial aspects of TS girls life seem to be impaired by low self-esteem, social isolation
and peer relationships. Differences in appearance, short stature and the delay in the onset of
puberty affect their self –esteem. They also may exhibit adjustment problems, anxiety and
social immaturity.
A particular phenotype may be present to a significant number of patients with Turner syn‐
drome called X ring Turner syndrome, having a X0 cell line, a ring X and almost every time
a 46XX cell line. A study of Kuntsi et al., concluded that the presence of X ring chromsome
leads to a reduction in cognitive performance, most of patients meeting criteria for mental
retardation and special education. [21]
XXY Klinefelter syndrome(KS)
In boys with KS, the diagnosis may be established at birth or may be delayed to late child‐
hood or adolescence since many of clinical features (delayed puberty, diminished or ab‐
sent secondary sex characteristics, diminished testes) manifest in this period accompanied
bycontinuousbehavioural  problems  and  externalizing  symptoms.  Adults  may  be  diag‐
nosed during evaluation for infertilityor gynecomastia. [22] When present, mental retarda‐
tion is usually mild. Verbal IQ scores measured in KS children are below average, while
Performance IQ is normal.
Knowledgeabout increasing risk for specific developmental reading and having impaired
verbal ability, in females with an extra X chromosome, the same hypothesis was raised
about men. An exhaustive literature review of Rovert et al. concluded that KS children man‐
ifest deficit in verbal abilities and language processing. They presented a pattern of under‐
achievement in school and a higher risk for dyslexia. [23]
IQ was found to be only 10-15 lower than the average peers in a control group of 13 years
old boys. The level of intellectual deficit increases with the number of X chromosome, men‐
tal retardation being identified to individuals with more than four X
Other extra sex chromosome phenotypes
Clinical and developmental impact of a supernumerary sex chromosome led to the studies
focused on establishing and recognising the physical and cognitive profiles of these disor‐
ders. Supernumerary X chromosome was proved to influence the cognitive development,
with direct impact on language. Each extra X chromosome reduces the overall IQ by 15–16
points. [24] In this way, individuals affected by sex chromosome aneuploidy have a higher
risk to develop mental retardation and significant psychopathology with every extra X chro‐
mosome. Since additional Y chromosomes are often accompanied by additional X chromo‐
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somes (48,XXYY, 49,XXXYY), it was difficult to pinpoint specific features in these
phenotypes that are unique to either the X or Y chromosome. [23] Some differences have
been observed althout:48, XXYY have higher scores in adaptive scales in daily living skills,
socialization, and communication. The groups with 48,XXXY and 49,XXXXY have lower
functioning cognitively compared to 48,XXYY, secondary to extra X. Every day living skills
are impaired in this group, but also socialization, and communication.
Clinical phenotype IQs range Behavioral phenotype
48,XXYY tall, with long legs
underdeveloped genitalia ,
hypergonadotropichypogonadism ,
gynecomastia
60 to 80 higher risk for internalizing and
externalizing symptoms;
anxiety and withdrawal
aggressive and delinquent behaviors
48,XXXY average to tall stature,
facial dysmorphism: hypertelorism, flat
nasal bridge, underdeveloped genitalia ,
hypergonadotropichypogonadism ,
gynecomastia
40 and 60 immaturity, passivity, with occasional
irritability,
temper tantrums, and outbursts
49,XXXXY microcephaly
coarse face, ocular hypertelorism, flat nasal
bridge, and upslanting palpebral fissures
underdeveloped genitalia ,
hypergonadotropichypogonadism ,
20 to 60
Table 2. Clinical and behavioral phenotype in supernumerary sex chromosome disorders .
Volumetric studies demonstrated significantly reduced brain volumes in subjects with XXX
and XXY, but not in XYY subjects, indicates that the presence of a extra X chromosome has a
demonstrable effect on brain development. In the same direction the research on the pres‐
ence of an extra Y chromosome couldn't be associated with significant volumetric brain dif‐
ferences relative to normal male controls. [25]
2.2. Contigous gene syndromes associated with cognitive deficits
In contiguous gene syndromes, the disorder is due to microdeletions or microduplications
of chromosomal segments associated with clusters of single gene disorders. These disorders
were recognized clinically prior to their cytogenetic localization. Usually the cytogenetic ab‐
normalities are detected by high-resolution chromosome analysis like FISH, but there may
be patients having submicroscopic molecular deletion. [26]
A particularity of contiguous gene syndromes is that loci that are physically contiguous
with the deleted zone have an phenotypic impact. The clinical expression of the phenotype
may vary from one individual to another depending on the extent of the deletion.
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Since most of the patients of these contiguous syndromes many present a degree of mental
retardation recommendation have been made for chromosome analyses to the patient with
mental retardation and mendelian traits that are not usually associated with mental retardation.
PraderWilli syndrome(PWS)
PWS is caused by a chromosomal deletion on chromosome 15. Most cases of PWS (about 70
%) occur when the paternal region 15q11-q13is deleted in each cell. In another 25 % of cases,
a person with PWS has two copies of chromosome 15 inherited from the mother – isodisomy
(UDP). Rarely, PWS can also be caused by a chromosomal translocation, or by a mutation or
other defect, that inactivates genes on the paternal chromosome 15. Approximately 1-5% of
patients have neither deletion nor UDP, but a small deletion inthe centre controlling the im‐
printing process within 15q11-13.[27]Each of these genetic changes results in a loss of gene
function in a critical region of chromosome 15. Due to imprinting, the maternally inherited
copies of these genes are virtually silent, only the paternal copies of the genes are expressed.
PWS results from the loss of paternal copies of this region.
On average people with PWS shows mild level of mental retardation, although individually
their IQ scores may range from average to profoundly mentally retarded. Repeated studies
since PWS had been discovered tried to establish a correlation between body mass index
with IQ[28]. No significant relation has been found.
Specifically, the syndrome includes a particular eating behaviour (a compulsive search for
food, non-selective non-discriminatory ingestion of large quantities of food and also, steal‐
ing food), irritability, reduced tolerance to frustration, stubbornness, anger, pinching skin,
associated, in the vast majority of patients with mild mental retardation. Typically, the be‐
havioural difficulties reach a peak in adolescence or in early adult life. Binge eating is the
most severe and debilitating behaviour disorder, leading to obesity, diabetes and severe res‐
piratory difficulties.
Usually, patients are happy and open to interpersonal networking, participating with inter‐
est in behavioural training. They can learn to structure their daily routine activities, rewards,
breaks, boundaries and firm rules.
An extensive study focused on assessing self-aggressive, stereotyped and obsessive compul‐
sive behaviour in individuals with PWS and showed that skin picking is found in 19.6% of
individuals, with low frequencies of nose pinching, kicking and pulling nails and lips hair.
From the compulsive behaviour category, the compulsive eating is the most common.
Standardized assessments have identified high levels of depressive, anxiety and compulsive
symptoms, with functioning impairment, which are not explained by developmental delays,
difficulties in nutrition or by obesity in patients with PWS.
Angelman Syndrome (AS)
Is a neurological disorder with a heterogeneous genetic causality.
70% cases of AS occur when a segment of the maternal chromosome 15 containing this gene
is deleted. In other cases, AS is caused by a mutation in the maternal copy of the UBE3A
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gene. AS results when a person inherits two copies of chromosome 15 from his or her father
instead of one copy from each parent- uniparental disomy(UPD). AS may also be caused by
a chromosomal rearrangement called a translocation, or by a mutation or other defect in the
region of DNA that controls activation of the UBE3A gene. These genetic changes can abnor‐
mally turn off UBE3A or other genes on the maternal copy of chromosome 15.
UBE3A gene codes for a protein called ubiquitin protein ligase E3A. Ubiquitin protein ligas‐
es is implicated in the process of removing unnecessary protein from cells and maintaining
the normal function of cells. In the brain UBE3A is expressed only from maternal allele [29],
and it has a higher density in hippocampus and the Purkinje cells from the cerrebellum.
Studies suggest that ubiquitin protein ligase E3A plays a critical role in the normal develop‐
ment and function of the nervous system.
The clinical picture comprises of psychomotor development delay, a joyful mood, hyper ex‐
citable personality, EEG recording anomalies and severe mental and language retardation.
Apparent happiness is brand forthe syndrome, associated with a vague smile, rare specific
laughs, exuberant background, hyperactive and stereotyped motor behaviour, and proac‐
tively social contact. Autistic symptoms lead to debates in diagnosis. The absence of expres‐
sive language, the reduced and inefficient use of nonverbal communication, motor and
sensory stereotypes and sleep problems have all been correlated with low development pro‐
file and were considered by some authors as “co-morbid autistic disorder”. Peters et al
(2004) have found an association between AS and autistic spectrum disorders (according to
DSM IV) in approximately one half of the evaluated cases. In addition, AS can be associated
in various degree with ataxia, epilepsy and microcephaly.[30] Some children can develop se‐
vere myoclonic seizures, knowing that myoclonus with cortical origin is another manifesta‐
tion of AS.
Williams syndrome (WS)
WS is characterized by particular facial appearance, with elfin appearance, cardiac abnor‐
malities/malformations, connective tissue abnormalities, mental retardation or learning dis‐
order, idiopathic infantile hypercalcemia, particular cognitive profile and an unusual
personality profile.
The disorder is caused by a deletion of 1.5 megabase the long arm of chromosome 7, includ‐
ing the elastin gene (ELN). 16 genes were identified, so far, in the region 7q11.23. [31] The
deleted region includes about 25 genes that probably contribute the manifestations of the
syndrome. ELN gene deletion responsible for the synthesis of elastin, is associated with con‐
nective and cardiovascular anomalies, which are characteristic for the syndrome (supravalv‐
ular aortic stenosis, supravalvular pulmonary stenosis). Deletions of LIMK1, GTF2I,
GTF2IRD1 genes are responsible for visual and spatial difficulties in these patients and the
CYLN2 gene deletion is associated with particular behaviour, mental retardation and other
cognitive deficiencies seen in patients with WS. The STX1A and LIMK1 gens are good candi‐
dates in investigating changes in cognitive or behavioural aspects of WS. LIMK1 gene was
discussed in causal relationship with visual and spatial characteristics of WS [32], whereas
the genes FZD9 and STX1A have been proposed to be involved in alterations of brain devel‐
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opment. A more severe phenotype with lower cognitive ability is found in individuals with
longer deletion (> 2.4 Mb) than typical deletion. Patients with a shorter deletion, that does
not involve GTF2I (including those with de novo mutation) do not have intellectual disabili‐
ty, but have the specific WS cognitive phenotype.
Miller-Dieker syndrome
Miller-Dieker syndrome is characterized by lissencephaly and facial dysmorphy.The majori‐
ty of the children have deletion of chromosome17p13.3.Children may present clinical fea‐
tures of Miller-Dieker syndrome by inheriting an unbalanced translocation.
The size of the deletion varies among affected individuals. The identified genes in this re‐
gion, implicated in features of Miller-Dieker syndrome are: PAFAH1B1, responsible for the
syndrome's characteristic sign of lissencephaly and YWHAE, which increases the severity of
the lissencephaly.
Brain malformations cause abnormal muscle tone, spasticity or hypotonia, developmental
delay, seizures severe intellectual disability, and feeding difficulties. PAFAH1B1 gene (also
known as LIS1) provides instructions for making a protein is thought to be involved in di‐
recting the movement of nerve cells (neurokinesis) in the brain. Proper neuronal migration
is essential for normal brain development and function. It also promotes neuronal migration
by interacting with tubulin in microtubules. [33]
Decreased amount of PAFAH1B1 protein produced by the deletion of one copy of the PA‐
FAH1B1 gene is responsible for many of the features of Miller-Dieker syndrome, including
intellectual disability, developmental delay, and recurrent seizures (epilepsy). A decrease in
neuronal migration caused by a lack of PAFAH1B1 protein is responsible for the lissencephaly.
YWHAE gene provides instructions for making the 14-3-3 epsilon (ε) protein, which is part
of the large of a protein family involved in cell signalling. The 14-3-3ε protein helps to regu‐
late a variety of processes including cell division and sensitivity to insulin in the body, in the
brain being involved in neuronal migration by binding to other proteins involved in this
process. It is thought that the 14-3-3ε protein is critical for proper neuronal migration and
normal brain development. [34]
Di George syndrome
Is also referred as velocardiofacial syndrome and is caused by deletion of one copy of the
22q11.2 region resulting in abnormalities in the development of the third and fourth bran‐
chial arches, producing thymic hypoplasia,  parathyroid hypoplasia,  and conotruncal car‐
diac defects.
Children have frequently learning disabilities and behavioural problems. Developmental
milestones are achieved later the peers of same age. In school age children IQ testing re‐
vealed scores that can range from average to mild retardation an a discrepancy between ver‐
bal and non-verbal IQ. The school performance may be lower than predicted by IQ testing
secondary to weak executive functioning and low verbal abilities. They have also high
scores in externalising symptoms secondary to attention deficit disorder, disinhibition and
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impulsivity, but also at internalising symptoms – shyness, anxiety and depression. In one
longitudinal study, 20% of VCFS children in mid adolescence had significant prodromal
psychotic symptoms. [35]
2.3. Monogenic mental retardation
Studies looking at single genes that may contribute to intellectual disability were started by
reports of numerous families in which intellectual disabilities were common and transmit‐
ted in Mendelian pattern. In the some of them, the trait was inherited X-linked and was
more frequent in males. The detailed analyses of _1000 Online Mendelian Inheritance in
Man (OMIM) database entries and of the literature through September 2003 revealed 282
molecularly identified MR genes. [54]
Gene Locus Disorder Protein function
CBP 16p13.3 Rubinstein–Taybi syndrome
CREB binding protein; chromatin-
remodelling factor involved in Ras/ERK/
MAPK signalling cascade
EP300 22q13.1 Rubinstein–Taybi syndrome
Transcriptional coactivator similar to CBP,
with potent histone acetyl transferase:
chromatin-remodelling factor
DNMT3B 20q11.2
ICF syndrome: immune deficiency
associated with centromeric instability,
facial dysmorphy and MR
DNA methyltransferase 3B, involved in
chromatin remodelling
GTF2RD1 7q11.23 Williams syndrome
Transcription factors, potential regulator
of c-Fos and immediate-early gene
expression
CRBN 3p25 Nonsyndromic AR mental retardation ATP-dependent protease; regulation ofmitochondrial energy metabolism
CC2D1A 19p13 Nonsyndromic AR mental retardation Unknown function, protein contains C2and DM14 domains
UBE3A 15q11 Angelman syndrome
Ubiquitin–protein ligase E3A; protein
degradation (proteasome): CNS
development/function
RELN 7q22 Lissencephaly with cerebellar hypoplasia Extracellular matrix (ECM) molecule, reelinpathway
VLDLR 9p24 Lissencephaly with cerebellar hypoplasia Low-density lipoprotein receptor, reelinpathway
POMT1 9q34 Walker–Warburg syndrome (also known asHARD syndrome**)
Protein o-mannosyltransferase 1
(glycosylation of alpha-dystroglycan)
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Gene Locus Disorder Protein function
POMT2 14q24.3 Walker–Warburg syndrome Protein o-mannosyltransferase 2(glycosylation of alpha-dystroglycan)
POMGnT1 1p34 Muscle–eye–brain disease (MEB) Protein o-mannose beta-1,2-n-acetylglucosaminyltransferase
Fukutin 9q31 Fukuyama congenital muscular dystrophy(FCMD) with type 2 lissencephaly
Homology with glycoprotein-modifying
enzymes (no biochemical activity has
been reported).
NF1 17q11 Neurofibromatosis type 1 (NF1); MR ispresent in 50% of NF1 cases
RasGAP function, involved in Ras/ERK/
MAPK signalling transcription cascade;
postsynaptic protein
Microcephalin 8p22-pter Microcephaly vera Cell cycle control and DNA repair
CDK5RAP2 9q33.1 Microchephalyvera Mitotic spindle function in embryonicneuroblasts
ASPM 1q31.1 Microchephalyvera Formation of mitotic spindle duringmitosis and meiosis
CENPJ 13q12.2 Microchephalyvera Localization to the spindle poles ofmitotic cells
Table 3. Autosomal genes involved in MR disorders [31, 36]
X-linked mental retardation (XLMR)
Since the observations of L. Penrose, in 1983, of existence of a higher number of males than
females with mental retardation in the population, several surveys were directed to eluci‐
date the etiology of this report. The results indicated that many genes that determine mental
retardation mapped for X chromosome. X-linked mental retardation (XLMR) was defined as
a monogenic intellectual disability affecting mostly males, having a higher prevalence of MR
relative to females.
The prevalence of XLMR had been estimated in different studied since 1980 the estimation
made by Herbst and Miller, of 1.83 affected in 1000 males. [37] Since the X-linked disorders
may be transmitted by an unaffected carrier mother, large families with numerous multige‐
nerational individuals with mental retardation facilitated linkage studies and supported the
idea of highly heterogeneous pathology.
Establishing the distribution of the level of cognitive deficit in the XLMR individuals group
was considered a important socio-economic problem giving the extensive impact of MR not
only for genetic and medical services but for social system. For mild mental retardation (IQ
70–50), the epidemiological studies found a ratio male- female of 1.9, indicating that 50% of
all the cases of mild MR are due to XLMR. For this result it was considered that the excess of
cases in males is due to XLMR. The same ratio is lower in moderate to severe MR (IQ<50), of
Genetic Disorders156
1.4, and making the same assumption than above we will conclude that 28.5% of all severely
retarded males have XLMR. A percent of 10–16% from all severely retarded men is due to
XLMR. Finally, in cohorts of mentally retarded males, the prevalence of the Fragile X syn‐
drome was 2–2.5%,[38,39], 25% of all males with severe XLMR have having Fragile X syndrome.
Nonspecific ornonsyndromic XLMR include mental retardation caused by mutations of genes
on the X chromosome without accompanying somatic, neurologic, biological, or behavioural
manifestations which allows distinction from nonaffected male or from males with identi‐
fied MR.
In other words, a nonprogressive intellectual disability, segregating in X linked manner that
can be distinguished based on the knowledge of their causative gene. The studies of this
type of XLMR were directed to establish the relation between X chromosome genes and the
cognitive and adaptive functions and processes.
The difficulties in establishing a characteristic pedigree increased the difficulties in establish‐
ing the prevalence.
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Figure 1. Gene function in nonsyndromic XLMR(Addapted after Hilger Ropers and Ben C. J, 2005)[40]
The description of an case as a nonsyndromic XLMR entity implies a complex evaluation in‐
cluding: growth, morphological features, neuromuscular development and function, behav‐
iour, brain imaging, and laboratory testing. Affected males were not prove to have
morphologic, neuromuscular, or behavioural manifestations that distinguish them from un‐
affected brothers or from other males with mental retardation. [40]. The degree of mental re‐
tardation could vary from mild to severe in the same family but is consistent. Carrier
females may experience less severe learning problems. They also lack diagnostic findings on
cranial imaging, biochemical studies, or cytogenetic analysis. Head circumferences and
heights in affected males were most often in the normal range. Testicular volumes had been
documented to be normal or enlarged.
Rett syndrome
Was described as a form of nonsyndromal XLMR. Mutation in gene MECP2 maps on chro‐
mosome Xq28.Rett syndrome it is frequently due to the deletion or insertion mutation in
MECP2 gene. In 25% from the cases MECP2 large deletion were identified by PCR in girls
with typical clinical picture. MECP2 gene is expressed in the brain in the neurons but not in
the glia.
Rett syndrome was included in the chromatin modification disorders category because of the
role of MECP2 in coding a protein that binds to chromatin and regulates transcription [41].
Clinical onset of the symptoms is early in the childhood, between 6-18 month, with loss of
speech, behavioural changes, stereotypical behaviours, loss purposeful use of hands. The lit‐
tle girls affected tend to loss contact and interest for communication, and to occupy their
time with repeated hand wringing, washing, or clapping motions. As they grew older mi‐
crocephaly became evident, motor regression, seizures are added. They may also have an al‐
tered pattern of sleep and breathing difficulties.
Syndromic XLMR
Syndromic or specific XLMR implies that beside mental retardation the affected individuals
present other manifestations that can include them in one of the categories:
1. syndromes, characterized by multiple congenital anomalies affecting organs and tissues
but also including the brain,
2. neuromuscular conditions, with associated neurologic and/or muscular symptoms,
3. metabolic conditions and
4. dominant conditions [42] .
This attempt to classify XLMR has most a theoretical. Thus,because the same genes or even
the same mutation can result in either a syndromic or a non-syndromic form of the disease.
One example can be ARX gene found both in patients with non-syndromic X-linked mental
retardation and in the syndromic X-linked West syndrome and Partington syndrome. [43]
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The explanation may be that mutations in these genes in nonsyndromic XLMR families are
presumed to cause only a partial loss of function of the encoded proteins, which could ex‐
plain the absence of syndromic features
The classification from the 2007 XLMR gens update accept three classes to categorize XLMR
conditions based on their clinical presentation:
a. syndromes, characterized by multiple congenital anomalies and defects in organs/
tissues other than (but also including) the brain;
b. neuromuscular disorders, characterized by neurological or muscular symptoms (epilep‐
sy, dystonia, spasticity, muscle weakness, and so on) but no malformations and
c. nonspecific conditions (MRX), where MR is the only consistent clinical manifestation
among the affected individuals. [42]
The conditions associated with MR are recognizable on the basis of a distinctive clinical pre‐
sentation and they can be considerate separate nosological entities, even if the causative
gene or locus is unknown.
This distinction has mostly practical value.
Gene Disorder Clinical features Protein function
FMR1 Fragile X syndrome Facial anomalies, macroorchidism mRNA processing, mRNA
export from nucleus
ABCD1 X-linked adrenoleukodistrophy Cognitive regression, spasticity,
seeing loss, dementia, Addison
disease
Membrane transporter,
peroxisome
MAOA MAO-A-deficiency behaviour Aggressive and violent MAO serotonin metabolism
OCRL1 Lowe syndrome Short stature, cataracts,
hypotonia, aminoaciduria,
progressive renal disease
Signal transduction, lipid
metabolism
GK Glycerol kinase deficiency Short stature, spasticity,
osteoporosis
Nuclear translocation of
the
hyperglycerolaemia
glucocorticoid-receptor
complex
XNP ATR-X, Juberg–Marsidi syndrome,
Carpenter syndrome,
Holmes–Gang of gene syndrome,
Smith–Fineman–Myers syndrome,
Chudley–Lowry syndrome
Spastic paraplegia
Microcephaly, hypotonic facies,
facial, urogenital and skeletal
anomaliesthalassaemia, HbH
inclusions, microcephaly, short
stature, spastic diplegia
DNA helicase; chromatin
remodelling, DNA
methylation and regulation
expression; regulator of
cortical size
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Gene Disorder Clinical features Protein function
FGD1 Aarskog–Scott syndrome Facial, digital and genital
anomalies, short stature
RhoGEF; possible role in
stimulation of
actin polymerization
RSK2 Coffin–Lowry syndrome Facial and skeletal anomalies Serine-threonine protein
kinase; CREB
phosphorilation; long term
memory
OPHN1 Cerebellar hypoplasia or dysplasia Epilepsy, cerebellar anomalies Negative control of
rhoGTPases; and epilepsy
stabilization of dendritic
arbours
MECP2 Rett syndrome
Male fatal neonatal encephalopathy
Progressive spasticity Spasticity
NS-XLMR 57
Angelman and Prader–Willi-like
phenotypes
Regression, epilepsy, acquired
microcephaly, hand stereotypies,
autism Hypotonia, apnea,
epilepsy
Transcriptional silencer of
neuronal genes
SLC6A8 Creatine deficiency syndrome Epilepsy, facial anomalies Creatine transporter,
maintenance of (phospho)
creatine pool in brain
FLNA Periventricular heterotopia
Otopalatodigital syndrome I and II
Epilepsy, brain anomalies, short
stature, cleft palate, facial and
skeletal anomalies
Actin-binding protein;
neuriteoutgrowth;dendritic
spine formation
ARX West syndrome
Partington syndrome X-
linkedlissencephaly,
ambiguousgenitalia
Proud syndrome
Infantile spasms, regression,
epilepsy, dystonia Lissencephaly,
corpus callosum agenesis,
epilepsy, ambiguous genitalia,
Microcephaly, corpus callosum
agenesis, urogenital anomalies
Transcription factor;
neuronal proliferation/
differentiation of GABA-
releasing neurons
CDKL5 Infantile spasms Infantile spasms Serine-threonine kinase;
chromatin remodelling
SYN1 Epilepsy, macrocephaly, aggression Epilepsy, macrocephaly,
aggression
Synaptic-vesicle associated
protein
SMS Snyder–Robinson syndrome Macrocephaly, palatal
anomalies,scoliosis
Spermine synthase
PQBP1 Renpenning syndrome,
Sutherland–Haan syndrome,
Hamel cerebro-palatocardiac
syndrome, Golabi–Ito–Hall
syndrome
Microcephaly, short stature,
slender habitus, long face,
congenital heart defect, cleft
palate
Polyglutamine-binding;
mRNA splicing
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Gene Disorder Clinical features Protein function
PHF6 Börjeson–Forssman–Lehmann
syndrome
Hypogonadism, obesity, facial
anomalies, epilepsy
PHD zinc-finger protein;
putative role in
transcription
SLC16A2 Thyroid and neurological
abnormalities
Hypotonia, spasticity, dystonia,
abnormal thyroid tests
Monocarboxylate
transporter; T3 transport
into the cytoplasm
BCOR Lenz microphthalmia Microphthalmia, skeletal and
urogenital anomalies
Transcriptional co-
repressor; possible rolein
modulation of histone
acetylation and chromatin
remodelling
PHF8 Siderius–Hamel cleft lip or palate
syndrome
Cleft lip or palate PHD zinc-finger protein;
putative role in
transcription
ATP6AP2 Epilepsy Epilepsy Renin receptor; activates
ERK1 and ERK2
JARIDIC Microcephaly, spasticity, epilepsy,
short stature, facial anomalies
Microcephaly, spasticity, epilepsy,
facial anomalies short stature,
Transcription
factor;chromatin
remodelling
IDS Hunter disease (MPZII) Short stature, skeletal and facial
abnormalities, hearing loss
Metabolism,
glycosaminoglycan
metabolism
PLP1 Pelizaeus-Merzbacher syndrome Nystagmus, truncalhypotonia and
progressive spastic
paraplegia, ataxia, and dystonia
associated with CNS
dysmyelination
Membrane component,
myelin component
HPRT1 SyndromeLesch-Nyhan Choreoathetosis, self-mutilation,
hyperuricemia
Metabolism, purine
ribonucleoside salvage
MID1 Opitz syndrome Macrocephaly, facial anomalies,
dysgenesis of corpus callosum,
cardiac defects,
hypotonia
Ubiquitin cycle,
microtubule-associated
complex
ATP7A Menkessyndrome Growth deficiency, sparse hair,
limited movement, hypertonicity,
seizures, arterial
tortuosity, childhood death
Membrane transporter,
copper-exporting ATPase
activity
Table 4. Gene function in syndromic XLMR(Adapted after: Chellyet a.2006, [ 31]).
Fragile X syndrome
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Fragile X syndrome is the most common form of XLMR, affecting approximately 25% of all
families suffering from XLMR. It is caused by the loss of function of gene FMR1, which
maps on chromosome Xq27.3, a55bp segment of DNA composed by repeats of the nucleo‐
tide CGG. CGG repeat is located in the 5฀-untranslated region of FRM1.[44] Normal people
have 6-55 copies, carriers have 55-230 copies and to not express the fragile site. In females
carriers the FRAX repeats are expanded during meiosis. In affected males 230-1000 repeats
are present and they express fragile X mental retardation. Repeat expansion associated with
hypermethylation causing reduced or absent expression of FRM protein. The accumulation
of untranslated FRM1 mRNA forms inclusion in neurons and glial cells of hippocampus and
cerebral cortex causing the neurological manifestations of the syndrome. [45,32]
Clinical features include long narrow face, large and protruding ears, macroorchidism. Pa‐
tients exhibit also moderate mental retardation, attention deficit, autistic symptoms, seizures
and coordination problems.
Autism
First described as a behavioral disorder in children, in 1943 by Leo Kanner, was proven
to affect  mostly  social  interactions,  the  interest  for  relation,  interaction and communica‐
tion, the ability to decode facial expression and emotional message. It was suggested that
autism has an organic basis sustained by the association with mental retardation (75%) and
seizures (40%).
Evidence of concordance in twin studies, monozygotic- 60-92%, while in dizygotic twins
range 0-10%, and the risk of recurrence higher than the general population in families with
one autistic child brought into scientific interest the role of genetic factors in autism. [46]
Autism may occur in patients with monogenic diseases as tuberous sclerosis or Fragile X
syndrome. Autistic like symptoms have also described in duplication of chromosome
15q11-13 [47] and deletion on chromosome 2q37.3 [48]
Between 1998 and 2004 an extended effort was carried out in the International Molecular
Genetic Study of Autism Consortium. The goal of associating a chromosome with autism
was not fulfilled but association studies have found positive association on chromosome 7q,
especially with a missense mutation on the LAMB1 gene, and with 17q11.2 [49]
The presence of autistic symptoms in Rett syndrome directed the attention through MECP2
gene. As a result, MECP2 mutation was associated with a low percentage in autism. The
same interest was raised by 15q11-13q, secondary to the presence of autistic features in indi‐
viduals with Prader-Willi syndrome and Angelman syndrome. The result in this cases was a
reduced expression of two genes in region 15q11-13q, UBE3A and GABRB3.
If the genomic regions play a role in autism, by genes defect or by common regulatory path‐
ways are the preoccupation of further studies.
2.4. Mental retardation in metabolic disorders
The evolution of metabolic disorders may disrupt development of children with previous
normal development. Genetic diseases presenting abnormal use or storage of different nor‐
Genetic Disorders162
mal substances (protein, lipids, copper), these disordersmay manifest with a complex per‐
turbation of cognition maturation and motor impairment.
DISORDER CLINICAL FEATURES
Biotinidase Deficiency Mental retardation, seizures, skin rash, loss of hair, death
Congenital Hypothyroidism Mental retardation, other brain damage, growthdelay
Galactosemia Severe brain damage, developmantal delay, kidney damage, eye
abnormalities inneonates, death
ORGANIC ACIDEMIAS
A condition in which the body cannot break down and get rid of certain organic acids and the metabolic acids
accumulate in blood
Glutaric Acidemia Type I Neurological deterioration, muscle weakness or dystonic
cerebral palsy, epilesy
Maple Syrup Urine Disease (MSUD) Neonatal coma, convulsions, mental retardation, death
Malonic Aciduria Developmental delay, vomiting, seizures, cardiomyopathy,
hypoglycemia
Isovaleric Acidemia Vomiting, lack of appetite, lethargy, neuromuscular irritability,
hypothermia
Propionic Acidemia Mental retardation, seizures, movement disorders, coma,
sudden death
Methylmalonic Acidemias Lethargy, vomiting and dehydration, respiratory distress, muscle
weakness, coma, seizures, developmental delay
Multiple Carboxylase Deficiency Seizures, immune system impairment, skin rashes, hair loss,
hearing loss, mental retardation
2-Methyl-3- Hydroxybutyryl CoA
Dehydrogenase
Deficiency
Developmental delay
3-Methylglutaconyl CoA Hydratase Deficiency Delayed motor development, short attention span,
delayeddevelopment of speech
DISORDERS OF AMINO ACID METABOLISM
A condition in which the body cannot break down several amino acids in protein foods and cannot get rid of
ammonia, which has a toxic impact
Arginase Deficiency Developmental delay, seizures, hyperactivity, ataxia
Argininosuccinate Lyase Deficiency Mental retardation, potential lethal coma, seizures, anorexia,
vomiting,
lethargy
Citrullinemia Mental retardation, potential lethal, coma, seizures, anorexia,
vomiting, lethargy
Homocystinuria Heart disease, stroke, possible mental retardation, psychiatric
problems
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DISORDER CLINICAL FEATURES
Phenylketonuria (PKU) Severe mental retardation, seizures
FATTY ACID OXIDATION DISORDERS (FAOD)
Problems with enzimes that breakdown of lipids from the food or from fat stored and production of Acetyl Co-
A. The proces requires active transport across mitochondrial membrane
Carnitine disorders
Carnitine/Acylcarnitine Translocase deficiency
(CAT)
Carnitine Palmitoyl Tranferase deficiency Type
I
(CPT-I)
Carnitine Palmitoyl Tranferase deficiency Type
II
(CPT-2)
Carnitine Uptake Defect (CUD)
hypoglycemia, liver disease, sudden infant death(SIDS),
encephalopathy, myopathy, cardiomyopathy.
Long chain fatty acid dehydrogenase disorders
Long/Very Long Chain Acyl CoA
Dehydrogenase deficiency (LCAD/VLCAD)
Long Chain Hydroxy Acyl CoA Dehydrogenase
deficiency (LCHAD)
hypoglycemia, hepatomegaly, myopathy, SIDS,Reye syndrome,
and cardiomyopathy.
Medium chain fatty acid dehydrogenase
disorders
Medium Chain Acyl CoA Dehydrogenase
deficiency (MCAD)
Medium Chain 3-Ketoacyl CoA Thiolase
deficiency (MCKAT)
Multiple Acyl CoA Dehydrogenase deficiency
(GA-II)
Children with MCAD are typically normal at birth and develop
episodes of hypoketotic hypoglycemia, vomiting, lethargy,
seizures associated with fasting.
Short chain fatty acid dehydrogenase disorders
Short Chain Acyl CoA Dehydrogenase
deficiency (SCAD)
Short Chain Hydroxy Acyl CoA Dehydrogenase
deficiency (SCHAD)
SCAD deficiency presents in the neonatal period with failure-to-
thrive, hypotonia, and metabolis acidosis; hyperammonemia
and lactic acidosis have been reported.
Glutaric acidemia (aciduria) types 1 and 2 Liver and muscle fat
Macrocephaly, brain atrophy (type 1)
Cortical dysplasias and heterotopias, polycystic kidneys (type 2)
MITHOCONDRIAL DISORDERS
The illness result from deficiency of any mitochondria-located protein which is involved in energy metabolism.
Variability in part due to variable numbers of affected mitochondria, and to the affected tissue, the most
damaged cells of the brain, heart, liver, skeletal muscles, kidney and the endocrine and respiratory systems.
Acute lactic acidosis
Leigh syndrome
Depending on the type of tissues affected, symptoms may
include:
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DISORDER CLINICAL FEATURES
MELAS
MERF
MIRAS
Pyruvate Dehydrogenase Deficiency
loss of motor control
muscle weakness and pain
respiratory complications
gastro-intestinal disorders and swallowing difficulties
poor growth
cardiac disease
liver disease
diabetes,
seizures
visual/hearing problems
lactic acidosis
developmental delays
GLYCOGEN STORAGE DISEASES
Abnormal metabolism of glycogen
Hypoglycemia and ketosis (variable)
Deposition of glycogen in tissues
MUCOPOLYSACCHARIDOSES
Defective normal degradation leads to
glycosaminoglycan accumulation
Because of maternal enzymes, patients normal at birth and then
progress to disfigurement and disability, coarsened facial
features
short stature with disproportionately short trunk and skeletal
dysplasia
thickened skin ,organomegaly , hernias, excessive body hair,
progressive joint stiffness
Developmental delay
Severe behavioral problems
Hearing loss
Communicating hydrocephalus
PEROXISOMAL DISORDERS
This results in the over-accumulation of and branched chain fatty acids, such as
Zellweger spectrum disorders
Zellweger Syndrome
Neonatal Adrenoleukodystrophy
Infantile Refsum Disease
Destruction of the myelin (demyelination) leads to loss of white
matter (leukodystrophy). Children may develop life-threatening
problems in other organs and tissues, such as the liver, heart,
and kidneys, adrenal glands
Chondrodysplasia Punctua spectrum abnormal cartilage and bone development, chondrodysplasia
punctata especially in the hands and feet, hearing loss and short
stature, cardiac defects, and seizure disorders
LEUKODYSTROPHIES
Genetically determined progressive disorders that affect the brain, spinal cord and peripheral nerves. The injury
affect the white matter of the nervous system and is progressive, tends to get worse as the child gets older.
Adrenoleukodystrophy
Alexander's disease
Canavan disease
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DISORDER CLINICAL FEATURES
Cerebrotendinous Xanthomatosis Krabbe's
disease
Pelizaeus-Merzbacher disease
LIPID STORAGE DISORDERS
Various disorders have characteristic patterns of organ involvement, depending on particular substrate that is
stored.
Mutation causes abnormal enzyme function. Leads to glycosphingolipid accumulation in lysosomes
Fabry disease
GM1 gangliosidosis
Tay–Sachs disease
Niemann-Pick disease
GM2 gangliosidosis
Gaucher disease
Wolman disesse
Fucosidosis
Alpha-manosidosis
Metacromatic leukodystropy
Galactosialidosis
Progressive clinical manifestations neurodegenerative disease,
organomegaly, skeletal abnormalities, pulmonary infiltrates
MENKES SYNDROME Alteration of copper metabolism. Children develop hypotonia,
seisures, hypotermia, developmental and grow delay.OCCIPITAL HORN SYNDROME
Table 5. Metabolic diseases associated with MR or DD.
Researches led to the understanding of mental retardation in these diseases and to identifi‐
cation and implementation of the therapies, which prevent the consequences associated to
the genetic defect. The positive results of therapies instituted in a timely manner put the ba‐
sis of extensive screening programs for newborns designed to avoid irreversible changes in
development processes.
2.5. Multifactorial inheritance and mental retardation
A clinical phenotype is frequently the result of a complexity of interaction between different
pathways including many genes, proteins and environmental factors. Such diseases are of
defective cellular migration (such as lissencephaly, heterotopias), neural tube defects, con‐
genital hydrocephalus, myoclonic epilepsy, and narcolepsy. The experiences showed that
these do not respect the Mendelian patterns of inheritance, althought genetic factors are im‐
plicated since a higher reccurence had been observed in some families.
The neural tube defect include spina bifida, anencephalyand any other defect that is a fail‐
ure of closure of the neural tube and, in some cases, hydrocephalus associated to thedisturb‐
ance of the circulation of the cerebrospinal fluid.
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Empirical data show that couples who have one child with a neural tube defect are at great‐
er risk of having a second child with a neural tube defect thanother couples in the general
population. Randomized controled data sustainned that maternal folic acid supplements
lower the the number of children born with spina bifida. [50]. Later studies sustained moth‐
ernal folic acid supplement for many months, even years, before conception for women of
having a child with a neural tube defect ( a previous child with neural tube defect, mother
taking antiepileptic medication).
Polymorphic DNA sequence variation could not sustain a single polymorphism in genes en‐
coding enzymes involved in folate metabolism as a risk factor factor in all populations for
neural tube defect. [51,52]
Genetic counselling for this families is important to take into consideration the neural tube
defect isolated and those in which it forms part of asyndrome.
3. Establishing the diagnosis of mental retardation
Developmental disabilities may affect children in a single domain or in several arias of their
life: global developmental delay, motor impairment, isolated speech and language delay, se‐
vere primary sensorial deficits and pervasive disabilities.
The earliest elucidation of the etiology of developmental delay may improve the quality of
child life. In inborn errors of amino acids or organic acids, a correct diagnosis improves the
evolution. Following an accurate clinical, biochemical, and sometimes molecular, a treat‐
ment could be initiated in this cases.
Even in the cases in which the diagnosis is not going to change the evolution for the child, a
positive impact may have on the family. A team approach may empower parents to deal
with disabilities and to search and choose proper medical, educational and social facilities.
The physician must be directed to evaluate child developmental level at every evaluation. A
suspicion of mental retardation in any child may be raised in any child based on some clues:
delayed speech, dysmorphic features (minor anomalies), difficult to manage temperament,
hypotonia generally or of the extremities, clumsiness, general inability to do things for self
and, not least, expressed concern by the parents.
1.Personal clinical history length of pregnancy, premature onset of labour or rupture of the membranes,
duration and course of labour, type of delivery and any complications, Apgar scores
at one and (especially) five minutes should be reviewed, and birth weight
length and head circumference measurements obtained and plotted on
appropriate growth charts
illnesses, feeding or sleeping difficulties in the newborn period and problems with
sucking or swallowing,
temperament
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atypical course in child development
seizures
Documented medical situations from prior evaluations may offer an objective perspective for the professionals.
2. Family history existing cases of DD/MR
history of infertility or fetal loss
maternal health during gestation: use of drugs, tobacco, alcohol, sign of infections,
hospitalisation, risk for sexually transmitted diseases
3. Dysmorphologic
examination
unusualcranio-facial, skeletal, palmar crease patterns.
macrocephaly; microcephaly
genital anormalities
Minor abnormalities, involving the face, ears, hands or feet may provide clues to developmental problems of
possible prenatal origin. Most minor abnormalities are readily recognized even on cursory examination.(53)
4. Developmental evaluationformal developmental screening
behaviour problems
ADHD
autism/autistic- like behaviours
The formal test that address developmental delay have more domains: gross motor/fine, speech-language,
cognition, social. For the physician it will be important to ask specific questions about the child's current
developmental abilities at each visit.
5. Neurologic examination -hypotonia, spasticity, ataxia
- seizures
- cerebral palsy
An EEG can be obtained when a child with global developmental delay has a history or examination features
suggesting the presence of epilepsy or a specific epileptic syndrome: Lennox-Gastaut syndrome, myoclonic
epilepsy, Rett syndrome.
If available, MRI should be obtained in the presence of physical findings (e.g., microcephaly, focal motor
findings).(53)
6. Endocrinologic
examination
-growth delay
-obesity
-genital abnormalities
- clinical signs for hypotiroidy
7. Other clinical examination
(cardiologist,
orthopedicsurgeon,
gynecologist,
ophthalmologist,
audiologist).
- heart malformations
-skeletal
Children with global developmental delay may undergo appropriate vision and audiometric assessment at the
time of their diagnosis. Vision assessment can include vision screening and a full ophthalmologic examination
(visual acuity, extra-oculo-movements, funduscopic). Audiometric assessment can include behavioural
audiometry or brainstem auditory evoked response testing when feasible. Transient evoked otoacoustic
emissions are used as screening studies in newborns.
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8. Karyotype common cytogenetic abnormalities found included Down syndrome, sex
chromosome aneuploidies (47, XXY), fragile X syndrome, and unbalanced
translocations/deletion syndromes
9. FISH microdeletion/microduplication abnormalities
10. Metabolic testing testing amino and organic acids
thyroid function
IGF
Table 6. Clinical genetics evaluation of the child with suspicion of MR.
Figure 2. Algorithm of evaluation in DD/MR
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Specific protocols for evaluation of children with DD/MR may be developed by every medi‐
cal service based on the implication of a complex team and having as one of the objectives to
keep the parents informed and facilitate the acquisition of the abilities and medical informa‐
tion that will make them able to manage their child at home.
4. Conclusion
Genetic factors have a major role in the etiology of mental retardation. In this chapter, we
made a review of the genetic causes in mental retardation disorders, from chromosomal ab‐
normalities, to contiguous gene syndromes, to monogenic mental retardation, to metabolic
disorders that present with mental retardation and multifactorial inheritance.
Tremendous research strains were made to determine the genetic substrate along with the
structural and functional impact of mental retardation. Firstly, efforts were targeted at un‐
derstanding the cause and the natural history of the mental retardation disorders. Secondly,
research aimed to precociously detect disorders (that can be treated), trough neonatal
screening. Positive economic and social impact was shown by the extensive experience in
screening, diagnosis and management of inborn errors of metabolism (PKU, hypothiroid‐
ism, organic acidemias). Unfortunately, most mental retardation syndromes do not have a
treatment, and in these cases, the management is very difficult, expensive and lifelong.
Thus, tailored professional support is needed for a family with a child with a mental retar‐
dation disease, in order to avoid social isolation and even isolation from the family. Access
to interventions, based on developing skills and methods of coping, emotional management,
support groups have reduced the negative impact on family functioning and established the
base for development of resources in the community.
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